Antibody-drug conjugates this novel approach represent a groundbreaking advancement in the struggle against cancer. ADCs fuse the targeting ability of antibodies with the destructive capability of cytotoxic drugs. By transporting these potent agents directly to malignant tissues , ADCs amplify treatment efficacy while reducing harm to healthy cells